A measured guide to how MMI may sharpen early ALS research.
This CREATE Consortium episode gives mild motor impairment, or MMI, a clear role in ALS research by turning a clinical question into something listeners can follow. Dr.

ALS research, carefully translated.
CReATe Podcast sits at the meeting point of ALS research, clinical guidance, and patient-facing explanation. Its episodes turn publications and ALS Untangled reviews into plain-spoken interviews about what evidence can and cannot yet show.
PRESS PLAY
CReATe Podcast is an ALS and motor-neuron-disease research show with a clear educational purpose. It turns consortium publications and ALS Untangled reviews into guided conversations for people who need the science explained without being flattened. Recent Author Series episodes center on MMI as a prodromal stage of ALS, C9orf72 disease-prevention trials, exercise and ALS, and clinical guidance for people at elevated genetic risk for ALS/FTD. Those topics are technical. The show meets them directly, using questions about phenoconversion, penetrance, mTOR signaling, endpoints, biomarkers, and clinical-trial design to show why small definitions can matter so much. The ALS Untangled strand is more evaluative. It examines alternative and off-label treatments such as the Wahls Protocol, psilocybin, ashwagandha, and zinc, asking what evidence exists, where animal or cell data may mislead, and whether potential benefits outweigh harms. The result is not a simple yes-or-no consumer guide. It is a habit of reasoning in public. A treatment can be cheap, available, or biologically plausible and still lack evidence for slowing ALS. Another can have enough signal to justify attention while still needing trial results before anyone treats it as settled. That distinction gives the show much of its value. The conversations also make room for the human stakes, including family experience with ALS and questions about genetic risk. Still, the center of gravity remains evidence. CReATe Podcast suits listeners who want research explained by people close to the work, with enough context to understand both promise and limits. It is sober, practical, and unusually comfortable saying that the answer is not known yet.
Made for: Suits a listener who wants patient-facing ALS research explanation without losing the clinical and trial-design details. It also fits families, advocates, and medically curious listeners comparing claims about alternative treatments against evidence.
What sets it apart: CReATe Podcast pairs consortium author interviews with ALS Untangled evidence reviews, so the same feed covers emerging research and practical questions about products advertised to people with ALS. Its strength is disciplined uncertainty: mechanisms, risks, and missing evidence stay visible.
CReATe Connect podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases.
The Wahls diet gets an evidence check before you rearrange your grocery list.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A measured guide to how MMI may sharpen early ALS research.
This CREATE Consortium episode gives mild motor impairment, or MMI, a clear role in ALS research by turning a clinical question into something listeners can follow. Dr.
A focused look at how prevention trials define disease onset before they can claim to prevent it.
This PlayNext review of C9-ORF72 disease prevention trials turns on a difficult question in preventive neurology: how does a study know when inherited risk has become illness?
A measured look at why extreme and moderate exercise may point in different directions for ALS risk.
Extreme exercise and ALS meet around a difficult biological question: why might very high activity be linked with higher risk while moderate exercise appears protective?




Oncology evidence translated into clinical decisions.

Critical care evidence, carefully talked through.

Clinical research, reduced to its practical signal.
["The CREATE Consortium Authors Podcast Series pairs Dr.
CReATe Podcast Ep.
Dr.
Dr.
Dr.
CReATe Podcast episode 16 follows Dr.
CReATe Podcast’s ALS Untangled Series Ep.
Dr. Heiman-Patterson describes her new at-risk clinic: baseline neurofilament and EMG, no evidence for repeat intervals, and "seat of the pants" follow-up.
Drs.
Dr.
Dr.
Dr.
Dr.
Dr.